The first AI-designed universal coronavirus vaccine passed its Phase I human trial in June 2026, was safe, with no side effects, and elicited immune responses against SARS and bat viruses.
Services & Resources
© 2026 Thefirmo. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Service and Privacy Policy.
Legal & Compliance
Company
Editorial & Sections
Services & Resources
© 2026 Thefirmo. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Service and Privacy Policy.